Fluorescence examination and photodynamic therapy of facial squamous cell carcinoma--a case report

Photodiagnosis Photodyn Ther. 2012 Mar;9(1):87-90. doi: 10.1016/j.pdpdt.2011.10.003. Epub 2012 Jan 9.

Abstract

Background and objective: To evaluate the usefulness and feasibility of fluorescence examination and photodynamic therapy (PDT) for facial squamous cell carcinoma.

Methods: A 68-year-old male patient underwent 3 courses of PDT. The first treatment was carried out using topically applied 5-aminolevulinic acid (ALA) to the affected area (5.0 cm × 2.5 cm) 3h before light irradiation. ALA/PpIX-mediated fluorescence was used to visualize the lesion and its margin. The lesion was illuminated with a 630 nm laser at 120 J/cm². Thirty days later, the residual lesion received the second treatment at the same light dose after topical use of ALA. Despite the tumor was treated with two courses of PDT, The lesion was not cleared completely yet. At last we used topical ALA and intravenous injection of HiPorfin, with the same light dose, then the lesion was cured and the patient was tumor-free followed up for over 15 months.

Results: ALA/PpIX-mediated fluorescence visualized the lesion location. Complete cure was achieved after the third course of ALA/Hiporfin PDT. During the 15 months of followed up, no recurrence was noticed.

Conclusion: ALA assisted fluorescence examination can be a useful tool to visualize the malignant lesion and determine its margin. ALA-PDT is effective for superficial lesions, but for thicker and deeper lesions, systemic administration of photosensitizer is indispensable.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aminolevulinic Acid / administration & dosage
  • Aminolevulinic Acid / therapeutic use*
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology
  • Hematoporphyrins / administration & dosage
  • Hematoporphyrins / therapeutic use*
  • Humans
  • Male
  • Neoplasms, Squamous Cell / drug therapy*
  • Neoplasms, Squamous Cell / pathology
  • Photochemotherapy / methods*

Substances

  • Hematoporphyrins
  • Aminolevulinic Acid